ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Extends PRI’s Fredrick Contract Six Months

September 23, 1994

Obit: John Ultmann, A Leader In Clinical Oncology.

October 27, 2000

Rich Left AMC “For Personal Reasons”

April 21, 1989

Bristol-Myers Adds Georgetown, MSK to Program

May 1, 1981

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

January 25, 2002

New Opportunities Still Abound In Immunology Program, Terry and other NCI Executives Say

February 27, 1976